eedq has been researched along with moxonidine in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Coupar, IM; Liu, L | 1 |
| Esteban, S; García-Sevilla, JA; Sastre-Coll, A | 1 |
2 other study(ies) available for eedq and moxonidine
| Article | Year |
|---|---|
Involvement of alpha-2 adrenoceptors in the effects of moxonidine on intestinal motility and fluid transport.
Topics: Adrenergic alpha-2 Receptor Agonists; Agmatine; Animals; Body Water; Brimonidine Tartrate; Dose-Response Relationship, Drug; Gastrointestinal Motility; Imidazoles; Male; Peristalsis; Quinolines; Quinoxalines; Rats; Rats, Wistar; Receptors, Adrenergic, alpha-2; Vasoactive Intestinal Peptide; Yohimbine | 1997 |
Effects of imidazoline drugs on tyrosine and tryptophan hydroxylase activity in rat brain in vivo.
Topics: Adrenergic alpha-Antagonists; Animals; Antihypertensive Agents; Benzofurans; Brain; Clonidine; Dihydroxyphenylalanine; Imidazoles; Male; Quinolines; Rats; Rats, Sprague-Dawley; Serotonin; Serotonin Antagonists; Tryptophan Hydroxylase; Tyrosine 3-Monooxygenase | 1999 |